- Collaborative Opportunities
NHLBI is seeking collaborators to enter into CRADAs and other forms of research partnerships.
- Licensing Opportunities
Innovative heart, lung, and blood-related technologies invented by NHLBI scientists and available for licensing to help ensure the technology is fully developed and available to the public.
- NIH Institutes Serviced by OTTAD
OTTAD provides its Clients with a full range of services including the negotiation of all types of technology transfer-related agreements.
- OTTAD Staff Page
OTTAD's primary mission is to enable researchers within the NHLBI Division of Intramural Research to interact more effectively with their counterparts in the private sector and in academia to:
- establish collaborative relationships that further develop existing technologies,
- facilitate the sharing of technologies with outside laboratories, and
- create innovative technologies in collaboration with others,
with the ultimate goal of benefitting the public health in a variety of basic, translational, and clinical areas, including imaging, diagnostics, regenerative medicine, genetics/genomics, developmental biology, cellular and gene therapy, and cell and molecular biology relating to heart, lung, blood, and sleep disorders and diseases.
To this end, OTTAD negotiates Cooperative Research Development Agreements (CRADA), Research Collaboration Agreements (RCA), Clinical Trial Agreements (CTA), Material Transfer Agreements (MTA), Confidential Disclosure Agreements (CDA), and other Technology Transfer transactional agreements on behalf of NHLBI that facilitate collaboration while protecting NHLBI's intellectual property interests.
OTTAD acts as the contact point within NHLBI for all new inventions made by NHLBI intramural researchers. The office advises the Scientific Director, intramural investigators and NHLBI leadership on issues relating to patenting and intellectual property. In addition, OTTAD manages NHLBI's large and diverse portfolio of technologies that are available for commercial licensing.
OTTAD works closely with its Clients to meet their technology transfer and intellectual property needs. OTTAD's Clients are the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the National Institute of Environmental Health Sciences (NIEHS), the National Institute on Deafness and Other Communication Disorders (NIDCD) and the National Institute of Nursing Research (NINR), including the NIH Center for Human Immunology, Autoimmunity and Inflammation (NIH CHI) and the NIH Center for Regenerative Medicine (NIH CRM).
NHLBI OTTAD Contact Information
Office of Technology Transfer and Development
31 Center Drive Room 4A29, MSC2479
Bethesda, MD 20892-2479
Last Updated: March 2014